PCM
DGX icon

Polaris Capital Management’s Quest Diagnostics DGX Stock Holding History

Polaris Capital Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-300
Closed -$52K – 108
2021
Q4 		$52K Hold
300
– – ﹤0.01% 102
2021
Q3 		$44K Hold
300
– – ﹤0.01% 101
2021
Q2 		$40K Sell
300
-338,534
-100% -$44.3M ﹤0.01% 103
2021
Q1 		$47.9M Sell
338,834
-17,200
-5% -$2.12M 1.57% 32
2020
Q4 		$42.4M Buy
356,034
+16,200
+5% +$1.97M 1.59% 32
2020
Q3 		$38.9M Sell
339,834
-6,322
-2% -$747K 1.92% 22
2020
Q2 		$39.4M Sell
346,156
-125,900
-27% -$13.4M 1.95% 14
2020
Q1 		$37.9M Sell
472,056
-3,600
-0.8% -$373K 2.29% 12
2019
Q4 		$50.8M Buy
475,656
+15,577
+3% +$1.62M 2.09% 16
2019
Q3 		$49.2M Buy
460,079
+11,200
+2% +$1.15M 2.21% 13
2019
Q2 		$45.7M Hold
448,879
– – 1.93% 17
2019
Q1 		$40.4M Buy
448,879
+12,400
+3% +$1.07M 1.68% 24
2018
Q4 		$36.3M Buy
436,479
+9,100
+2% +$853K 1.67% 21
2018
Q3 		$46.1M Buy
427,379
+30,882
+8% +$3.39M 2.01% 17
2018
Q2 		$43.6M Sell
396,497
-179,900
-31% -$18.7M 2.02% 14
2018
Q1 		$57.8M Buy
576,397
+177,600
+45% +$18.2M 2.13% 23
2017
Q4 		$39.3M Buy
398,797
+21,500
+6% +$2.04M 1.84% 24
2017
Q3 		$35.3M Buy
377,297
+30,600
+9% +$3.25M 1.98% 23
2017
Q2 		$38.5M Buy
346,697
+1,400
+0.4% +$148K 2.27% 11
2017
Q1 		$33.9M Buy
345,297
+700
+0.2% +$66.7K 2.41% 11
2016
Q4 		$31.7M Buy
344,597
+76,400
+28% +$6.58M 2.05% 14
2016
Q3 		$22.7M Sell
268,197
-9,100
-3% -$764K 1.77% 12
2016
Q2 		$22.6M Buy
277,297
+1,200
+0.4% +$91.4K 1.96% 12
2016
Q1 		$20.8M Buy
276,097
+37,586
+16% +$2.52M 1.78% 16
2015
Q4 		$17M Buy
238,511
+40,714
+21% +$2.74M 1.72% 15
2015
Q3 		$12.2M Buy
197,797
+14,400
+8% +$1.01M 1.47% 20
2015
Q2 		$13.3M Hold
183,397
– – 1.63% 14
2015
Q1 		$14.1M Buy
183,397
+2,150
+1% +$154K 1.97% 9
2014
Q4 		$12.2M Buy
+181,247
New +$11.4M 2.04% 15

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

Polaris Capital Management's DGX Position: Q1 2022 in Review

Polaris Capital Management sold out of Quest Diagnostics (DGX) in Q1 2022, closing a stake of 300 shares — an estimated $52K sold.

Polaris Capital Management first reported a position in DGX in Q4 2014 and held it in 29 quarters. The position peaked at $57.8M in Q1 2018. 851 funds tracked by Wall St. Rank hold DGX as of Q1 2022.

  • Polaris Capital Management reported no remaining Quest Diagnostics position as of Q1 2022 after selling out during the quarter.
  • Polaris Capital Management sold 300 Quest Diagnostics shares in Q1 2022, an estimated $52K.
  • Polaris Capital Management first reported a position in Quest Diagnostics in Q4 2014 and held it in 29 quarters.
  • Polaris Capital Management's Quest Diagnostics position peaked at $57.8M in Q1 2018.
  • 851 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2022.

Based on Polaris Capital Management's 13F filing for Q1 2022, filed 11 May 2022.